Tikehau Capital, Sprim join forces with new S'pore-based life sciences VC fund
Singapore
LIFE science startups hoping for a big break can now look to a new Singapore-based cash cow for funding.
European asset manager Tikehau Capital and Sprim Ventures, the venture arm of global healthcare consultancy Sprim, have teamed up to launch a venture capital (VC) fund for early-stage investments.
TRENDING NOW
Xi Jinping has just rewritten the rules of US-China rivalry
‘Whole deck of cards just toppled’: FoodXervices’ Nichol Ng on how a 92-year-old family business unravelled – and what’s next
In the EV race, Japan’s most dangerous rival could be closer to home than China
Wilmar, Musim Mas among palm-oil firms in Indonesia under probe for suspected export under-invoicing